Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 51.03%18.04M | 51.03%18.04M | 141.14%11.95M | 141.14%11.95M | -77.19%4.95M | -77.19%4.95M | 98.61%21.71M | 98.61%21.71M | 18.97%10.93M | 18.97%10.93M |
| -Cash and cash equivalents | 51.03%18.04M | 51.03%18.04M | 141.14%11.95M | 141.14%11.95M | -77.19%4.95M | -77.19%4.95M | 98.61%21.71M | 98.61%21.71M | 18.97%10.93M | 18.97%10.93M |
| Long term equity investment | 1.68%392.7M | 1.68%392.7M | 13.13%386.2M | 13.13%386.2M | 11.32%341.36M | 11.32%341.36M | -17.54%306.64M | -17.54%306.64M | 37.92%371.87M | 37.92%371.87M |
| Receivables | -5.53%1.28M | -5.53%1.28M | -2.16%1.36M | -2.16%1.36M | -30.42%1.39M | -30.42%1.39M | -39.91%1.99M | -39.91%1.99M | 361.06%3.32M | 361.06%3.32M |
| -Accounts receivable | -5.53%1.28M | -5.53%1.28M | -2.16%1.36M | -2.16%1.36M | -30.42%1.39M | -30.42%1.39M | -39.91%1.99M | -39.91%1.99M | 361.06%3.32M | 361.06%3.32M |
| Deferred assets | ---- | ---- | ---- | ---- | --786K | --786K | ---- | ---- | ---- | ---- |
| Total assets | 3.13%412.02M | 3.13%412.02M | 14.64%399.5M | 14.64%399.5M | 5.49%348.49M | 5.49%348.49M | -14.44%330.35M | -14.44%330.35M | 38.12%386.11M | 38.12%386.11M |
| Liabilities | ||||||||||
| Derivative product liabilities | -54.66%73K | -54.66%73K | -38.08%161K | -38.08%161K | 333.33%260K | 333.33%260K | 27.66%60K | 27.66%60K | --47K | --47K |
| Payables | 69.32%149K | 69.32%149K | -37.59%88K | -37.59%88K | -87.10%141K | -87.10%141K | 1,216.87%1.09M | 1,216.87%1.09M | -52.57%83K | -52.57%83K |
| -Accounts payable | 69.32%149K | 69.32%149K | -37.59%88K | -37.59%88K | -87.10%141K | -87.10%141K | 1,216.87%1.09M | 1,216.87%1.09M | -52.57%83K | -52.57%83K |
| Current deferred liabilities | 771.18%5.99M | 771.18%5.99M | 140.21%687K | 140.21%687K | -97.21%286K | -97.21%286K | 82.68%10.24M | 82.68%10.24M | 406.32%5.61M | 406.32%5.61M |
| Non current deferred liabilities | -0.34%43.18M | -0.34%43.18M | 57.01%43.33M | 57.01%43.33M | 53.43%27.6M | 53.43%27.6M | -60.06%17.99M | -60.06%17.99M | 92.76%45.04M | 92.76%45.04M |
| Total liabilities | 11.58%49.39M | 11.58%49.39M | 56.51%44.27M | 56.51%44.27M | -3.73%28.28M | -3.73%28.28M | -42.13%29.38M | -42.13%29.38M | 106.01%50.77M | 106.01%50.77M |
| Shareholders'equity | ||||||||||
| Share capital | -0.08%226.91M | -0.08%226.91M | 1.47%227.1M | 1.47%227.1M | 0.91%223.82M | 0.91%223.82M | 6.13%221.8M | 6.13%221.8M | 10.24%208.99M | 10.24%208.99M |
| -common stock | -0.08%226.91M | -0.08%226.91M | 1.47%227.1M | 1.47%227.1M | 0.91%223.82M | 0.91%223.82M | 6.13%221.8M | 6.13%221.8M | 10.24%208.99M | 10.24%208.99M |
| Retained earnings | -21.68%20.76M | -21.68%20.76M | 19.82%26.51M | 19.82%26.51M | 51.87%22.12M | 51.87%22.12M | 54.10%14.57M | 54.10%14.57M | -1.08%9.45M | -1.08%9.45M |
| Gains losses not affecting retained earnings | 13.12%114.96M | 13.12%114.96M | 36.85%101.63M | 36.85%101.63M | 14.95%74.26M | 14.95%74.26M | -44.74%64.6M | -44.74%64.6M | 109.66%116.9M | 109.66%116.9M |
| Total stockholders'equity | 2.08%362.63M | 2.08%362.63M | 10.94%355.23M | 10.94%355.23M | 6.39%320.2M | 6.39%320.2M | -10.25%300.97M | -10.25%300.97M | 31.56%335.34M | 31.56%335.34M |
| Total equity | 2.08%362.63M | 2.08%362.63M | 10.94%355.23M | 10.94%355.23M | 6.39%320.2M | 6.39%320.2M | -10.25%300.97M | -10.25%300.97M | 31.56%335.34M | 31.56%335.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |